Skip to main content
On Demand

Emerging Cannabinoids: Unique Legal and Regulatory Issues


Average Rating:
Not yet rated
Bundle(s):
CLI2022 On-Demand
Categories:
Emerging Cannabinoids |  Cannabis |  Cannabis Science
Faculty:
Neil Willner |  Shawn Hauser |  Rod Kight |  Sibyl Swift
Duration:
1 Hour
Format:
Audio and Video
SKU:
INCBA09302022emercannOD
License:
Access for 6 month(s) after purchase.



Description

This panel will cover the rapidly expanding market for cannabinoids other than CBD, including intoxicating cannabinoids from hemp. We will discus the cannabinoids most likely to emerge on the market and describe how they are produced, marketed, and their effects on humans. Panelists will review the unique legal and regulatory issues that emerging cannabinoids present to lawyers and strategies for addressing them. Throughout this presentation, the experts will engage substantively with each other about differences in opinions in an effort to tease out nuanced, often overlooked, and unsettled areas of law.

Credits


General

This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules. 

INCBA webinars are generally eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.

The on-demand version of this webinar is eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees.

(Default credit disclaimer updated 02.08.2024)


For current accreditation status, please select your jurisdiction below.



Handouts

Faculty

Neil Willner's Profile

Neil Willner Related Seminars and Products

Principal

NMW Advisors


Neil M. Willner is Co-chair of the firm’s Cannabis Group. He focuses his practice on the cannabis industry and provides counsel to hemp and marijuana companies across all parts of the supply chain on regulatory and compliance issues. Neil also handles regulatory compliance, investigatory due diligence, mergers and acquisitions, and litigation matters for firm clients. He advises buyers and sellers on regulatory considerations in mergers and acquisitions in many East Coast states.

Neil also participates on cannabis-related trade association committees including the New York State Bar Association’s Cannabis Law Section where he serves on the Executive Committee and chairs the Regulatory sub-committee, the International Cannabis Bar Association, and the American Trade Association for Cannabis and Hemp (ATACH). As Regulatory Counsel to ATACH, Neil helps create policy at the state and federal levels. He is working closely with the recently launched ATACH Cannabis Beverage Council to ensure beverages are permissible form factors in upcoming medical and recreational marijuana programs.

Neil is a prolific writer, co-authoring a chapter in the 2020 edition of Thomson Reuters Health Law Handbook, as well as a chapter in the American Health Law Association’s Health Care and the Business of Cannabis Questions and Answers book.

Neil also serves as a trusted expert to media outlets and has been quoted in articles published by the New York Times, the Village Voice, Forbes, and Lawyer.com.


Shawn Hauser's Profile

Shawn Hauser Related Seminars and Products

Partner

Vicente LLP


Shawn Hauser is a partner at Vicente LLP, where she co-chairs the firm's Hemp and Cannabinoids Department and serves as a leading member of the firm's Psychedelics and Emerging Therapies practice. She helps cannabis, hemp, and psychedelics businesses navigate the intersections between state and federal law, including cannabis and psychedelics laws and food and drug laws as they evolve. Her practice focuses on regulatory compliance, licensing, general business representation, investment advice, policy reform and strategic guidance to best position businesses for success at the at state, national, and international levels.

With more than a decade of experience in cannabis law and policy, Shawn is a go-to source for businesses, industry groups, governments, and reporters seeking opinions, analysis, and guidance. She has presented on cannabis law and policy to many local, federal, and international agencies, including the U.S. Food and Drug Administration and UK Parliament.

Since directing Sensible Colorado's local government implementation team following the passage of Amendment 64, Shawn remains active in policy work with local and state governments in Colorado and Texas. She is passionate in supporting the development and implementation of cannabis, hemp, and psychedelics regulations that advance the industries in a dynamic and responsible manner. Active in the community, Shawn currently serves on the Board of Directors of the International Cannabis Bar Association and previously served on the steering committee of the American Hemp Campaign—a project of Vote Hemp—which was instrumental in legalizing hemp in Texas in 2019.

Well-regarded in her field, Shawn has received many accolades. She was named one of the top cannabis lawyers in the United States Chambers and Partners and was recognized by her peers in The Best Lawyers in America® for her work in cannabis law. Additionally, Shawn has been listed in 5280 magazine's "Denver's Top Lawyers" list since 2015 and was included in Denver Business Journal's "40 Under 40" in 2021.

After attending law school at the University of Denver, Shawn was an associate attorney at McAllister, Darnell & Gottlieb PC, one of the first marijuana-focused law firms in Colorado.(32) Shawn Hauser | LinkedIn


Rod Kight's Profile

Rod Kight Related Seminars and Products

Attorney | Author | Advocate

Kight Law Office, PC


Rod is a cannabis business law attorney. Based in North Carolina and Mexico, Rod represents legal cannabis businesses throughout the world and is editor and chief writer of the Kight On Cannabis law blog. Rod is the author of “Cannabis Business Law-What You Need to Know”, published by Aspatore Books. He has served on the advisory board for the American Journal of Endocannabinoid Medicine, for which he has also written a legal column. Rod also created the “Source Rule”, which is widely regarded as a primary legal foundation for the contemporary hemp market in cannabinoids and other cannabis materials.

Rod is frequently quoted on cannabis matters by trade publications and major media outlets including the Wall Street Journal, Time, Politico, and Business Insider. Additionally, Rod has been listed in MG Magazine's list of "30 Powerful Litigators", Hemp Connoisseur Magazine’s list of “100 People You Should Know”, and High Time's "2020 Leaders in Cannabis Law." He is part of the legal teams in two high-profile cases against the DEA and the Texas Department of State Health Services regarding hemp extracts, has drafted and presented cannabis legislation to a foreign head of state, is a member of the board of directors of a publicly traded Canadian cannabis and psychedelics company, testified to the FDA about CBD and cannabis compounds, and is a partner in a Mexican import-export company focused on legal cross-border hemp transactions. Rod routinely advises in-house counsel and C-suite level executives on cannabis issues. He has discussed cannabis legal issues in numerous seminars to lawyers, business executives, and public officials and is regularly asked to be a guest speaker on US and inter- national podcasts about cannabis and psychedelics.

Rod is a strong believer in cannabis for personal and medical use after using it successfully during chemotherapy treatments for cancer (he is in remission). He has been an attorney advocate for NORML and has also been a member of the International Cannabis Bar Association, the National Cannabis Industry Association, the Hemp Industries Association, and the Southeast Hemp Association.


Sibyl Swift's Profile

Sibyl Swift Related Seminars and Products

VP of Scientific & Regulatory Affairs

CbdMD


Prior to joining cbdMD, Dr. Swift was the Senior VP for Scientific & Regulatory Affairs at the Natural Products Association (NPA) where she led the association’s work in Codex, the Supplement Safety & Compliance Initiative (SSCI), and FDA policy. Prior to her time at the NPA, Dr. Swift was the associate director for research and strategy at the US Food and Drug Administration (FDA), where she directed the Office of Dietary Supplement Programs research agenda and worked closely on office policy and enforcement.

Dr. Swift will oversee the CbdMD’s GMP compliance, internal product quality and safety initiatives, and direct the Company’s scientific work performed in support of world-wide regulatory submissions and claims substantiation. These efforts, and her outside work with standards setting organizations, such as AOAC’s CASP group demonstrates the Company’s continued commitment to providing its consumers with products that meet the highest regulatory standards for quality and safety.


Reviews